Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fractures, Bone | 1 | 2026 | 200 | 0.820 |
Why?
|
| Pregnancy Complications | 1 | 2026 | 549 | 0.680 |
Why?
|
| Contraceptive Agents, Male | 3 | 2024 | 37 | 0.550 |
Why?
|
| Small Molecule Libraries | 4 | 2024 | 135 | 0.460 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2024 | 606 | 0.460 |
Why?
|
| Drug Discovery | 4 | 2024 | 178 | 0.410 |
Why?
|
| Virus Replication | 3 | 2026 | 597 | 0.260 |
Why?
|
| Virus Release | 1 | 2026 | 6 | 0.240 |
Why?
|
| Flavivirus | 1 | 2026 | 25 | 0.240 |
Why?
|
| Electron Microscope Tomography | 1 | 2026 | 24 | 0.240 |
Why?
|
| Nuclear Proteins | 2 | 2022 | 1227 | 0.230 |
Why?
|
| Activin Receptors, Type I | 1 | 2024 | 34 | 0.220 |
Why?
|
| Contraception | 1 | 2024 | 62 | 0.200 |
Why?
|
| beta-Lactamase Inhibitors | 1 | 2023 | 65 | 0.200 |
Why?
|
| Protease Inhibitors | 1 | 2021 | 95 | 0.170 |
Why?
|
| Encephalitis Virus, Japanese | 1 | 2020 | 22 | 0.170 |
Why?
|
| Azepines | 1 | 2021 | 62 | 0.170 |
Why?
|
| Lipid Droplets | 1 | 2020 | 51 | 0.160 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 298 | 0.160 |
Why?
|
| Triazoles | 1 | 2021 | 144 | 0.160 |
Why?
|
| Capsid Proteins | 1 | 2020 | 150 | 0.160 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2020 | 249 | 0.150 |
Why?
|
| DNA | 4 | 2024 | 1444 | 0.140 |
Why?
|
| Structure-Activity Relationship | 3 | 2024 | 578 | 0.130 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 704 | 0.120 |
Why?
|
| Pregnancy | 1 | 2026 | 7558 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 1802 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 2558 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2021 | 2430 | 0.090 |
Why?
|
| Testis | 2 | 2024 | 413 | 0.080 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2021 | 135 | 0.080 |
Why?
|
| Molecular Docking Simulation | 2 | 2021 | 147 | 0.080 |
Why?
|
| Humans | 9 | 2026 | 130931 | 0.070 |
Why?
|
| Virus Assembly | 1 | 2026 | 37 | 0.060 |
Why?
|
| Mice | 4 | 2026 | 18410 | 0.060 |
Why?
|
| Virion | 1 | 2026 | 116 | 0.060 |
Why?
|
| Genome, Viral | 1 | 2026 | 155 | 0.060 |
Why?
|
| Activin Receptors, Type II | 1 | 2024 | 31 | 0.060 |
Why?
|
| Endoplasmic Reticulum | 1 | 2026 | 208 | 0.060 |
Why?
|
| Animals | 5 | 2026 | 34278 | 0.050 |
Why?
|
| Blood-Testis Barrier | 1 | 2024 | 14 | 0.050 |
Why?
|
| Receptors, Eph Family | 1 | 2024 | 22 | 0.050 |
Why?
|
| Receptor, EphA2 | 1 | 2024 | 29 | 0.050 |
Why?
|
| Cryoelectron Microscopy | 1 | 2026 | 238 | 0.050 |
Why?
|
| beta-Lactams | 1 | 2023 | 57 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2026 | 513 | 0.050 |
Why?
|
| Penicillins | 1 | 2023 | 154 | 0.050 |
Why?
|
| Female | 2 | 2026 | 70755 | 0.050 |
Why?
|
| Molecular Conformation | 1 | 2021 | 98 | 0.040 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2021 | 15 | 0.040 |
Why?
|
| Protein Conformation, beta-Strand | 1 | 2021 | 14 | 0.040 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2021 | 15 | 0.040 |
Why?
|
| beta-Lactamases | 1 | 2023 | 219 | 0.040 |
Why?
|
| Protein Domains | 1 | 2022 | 249 | 0.040 |
Why?
|
| Endometriosis | 1 | 2024 | 184 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2023 | 844 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2021 | 320 | 0.040 |
Why?
|
| Genetic Engineering | 1 | 2021 | 162 | 0.040 |
Why?
|
| Capsid | 1 | 2020 | 96 | 0.040 |
Why?
|
| Cell Movement | 1 | 2024 | 874 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2021 | 586 | 0.040 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 117 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2021 | 365 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2021 | 785 | 0.040 |
Why?
|
| Ligands | 1 | 2021 | 485 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 255 | 0.040 |
Why?
|
| Binding Sites | 1 | 2021 | 1200 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2021 | 1084 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 1625 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2021 | 1311 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2021 | 900 | 0.030 |
Why?
|
| Protein Binding | 1 | 2021 | 1705 | 0.030 |
Why?
|
| Gene Expression | 1 | 2021 | 1500 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2020 | 2560 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2021 | 2965 | 0.030 |
Why?
|
| Cell Line | 1 | 2020 | 2596 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2021 | 981 | 0.030 |
Why?
|
| Brain | 1 | 2026 | 3161 | 0.030 |
Why?
|
| Male | 3 | 2024 | 64823 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2024 | 4645 | 0.020 |
Why?
|